Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Details Emerge About China’s Investigation of GSK

publication date: Jul 9, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
About a week after China officials raided three major GlaxoSmithKline offices in China, looking for evidence of “economic crimes,” more of the story has been revealed. It is alleged that GSK’s sales force in Chengdu hatched a scheme to pay doctors to prescribe Botox, the wrinkle treatment, offering payments up to $490. Apparently, China authorities have proof that GSK’s salespeople talked about a pay-per-prescription plan. However, so far, they do not have evidence that any doctors were actually paid. More details....

Stock Symbol: (NYSE: GSK)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners